Pharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

By Pea Federico  

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 287-295

Adis International

Access to resources Recommend Favorite

Rapid Resolution of Symptoms with Moxifloxacin Therapy in 7223 Patients with Acute Exacerbation of Chronic Bronchitis: Comparison with Prior Macrolide Treatment

By Bauer T.  

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 641-651

Adis International

Access to resources Recommend Favorite

Moxifloxacin in Acute Exacerbations of Chronic Bronchitis: Clinical Evaluation and Assessment by Patients

By Lorenz J   Busch W   Thate-Waschke I-M    

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 61-73

Field House Publishing

Access to resources Recommend Favorite

Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis

By Starakis I.   Gogos C.A.   Bassaris H.  

International Journal of Antimicrobial Agents, Vol. 23, Iss. 2, 2004-02 ,pp. : 129-137

Elsevier

Access to resources Recommend Favorite

A Multinational, Multicentre, Non-blinded, Randomized Study of Moxifloxacin Oral Tablets Compared with Co-amoxiclav Oral Tablets in the Treatment of Acute Exacerbation of Chronic Bronchitis

By Schaberg T   Ballin I   Huchon G   Bassaris H   Hampel B   Reimnitz P    

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 314-328

Field House Publishing

Access to resources Recommend Favorite